Company / Cash & Equivalents
IRIDEX CORP Cash & Equivalents History
FY2015-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$6.0M
FY2026
5-year range
$2.4M / $23.9M
FY2022-FY2026
Trend
+152.5%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2026 after 3 years of decline, reaching $6M.
Based on SEC 10-K filings.
$6M in FY2026 with a 10-year CAGR of -7.6%.
Declined from $7M to $6M over the past 3 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- -24.0%
- 10-Year CAGR
- -7.6%
Key checks
Key Insights
- 5-year CAGR of -24.0%, indicating a declining trend.
- In FY2026, cash & equivalents increased 152.5% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
- Lowest cash & equivalents in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $6.0M | +152.5% |
| FY2024 | $2.4M | -66.1% |
| FY2023 | $7.0M | -49.5% |
| FY2022 | $13.9M | -41.6% |
| FY2021 | $23.9M | +88.5% |
| FY2019 | $12.7M | -40.3% |
| FY2018 | $21.2M | -10.8% |
| FY2017 | $23.7M | +78.5% |
| FY2016 | $13.3M | -1.0% |
| FY2015 | $13.4M | +13.0% |
As of FY2026 · SEC 10-K · Updated Jun 24, 2026